Clinical Trial Update: A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse [Phase 2]

View source ↗

Summary

Phase 2 trial comparing one-week-on/one-week-off temozolomide versus continuous dose-dense temozolomide in patients with glioblastoma at first relapse has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Beijing Sanbo Brain Hospital | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED